Lawrence A. Leiter
Lawrence Alan LeiterMDCM, FRCPC, FACP, FACE, FAHA
Professor
Departments of Medicine and Nutritional Sciences

Contact Info

T. (416) 867-7441

Location

St. Michael's Hospital
61 Queen Street East, 6th Floor
Toronto
ON, M5C 2T2

Accepting

Not accepting new students

Research/Teaching

Research Synopsis:

Major clinical research areas include:

  • Clinical trials on the prevention of atherosclerosis, especially in diabetes
  • Dietary and pharmacologic treatment of diabetes mellitus, hyperlipidemia, hypertension, and obesity.
  • Investigator in many of the landmark diabetes trials including the DCCT, ACCORD, and ADVANCE and is on the Executive/Steering Committees of many ongoing outcome trials in both the diabetes and lipid areas.

Publications and Awards

Recent Publications

Leiter LA, Teoh H, Braunwald E, Mosenzon O, Cahn A, Kumar KM, Smahelova A, Hirshberg B, Stahre C, Frederich R, Bonnici F, Scirica BM, Bhatt DL, Raz I; Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial. SAVOR-TIMI 53 Steering Committee and Investigators. Diabetes Care. 2015 Jun;38(6):1145-53.

Leiter LA, Astrup A, Andrews RC, Cuevas A, Horn DB, Kunešová M, Wittert G, Finer N.Identification of educational needs in the management of overweight and obesity: results of an international survey of attitudes and practice. Clin Obes. 2015 Oct;5(5):245-55.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. SAVOR-TIMI 53 Steering Committee and Investigators. N Engl J Med. 2013 Oct 3;369(14):1317-26.

Leiter LA, Berard L, Bowering CK, Cheng AY, Dawson KG, Ekoé JM, Fournier C, Goldin L, Harris SB, Lin P, Ransom T, Tan M, Teoh H, Tsuyuki RT, Whitham D, Woo V, Yale JF, Langer A. Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes. 2013 Apr;37(2):82-9.

Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).Can J Cardiol. 2011 Mar-Apr;27(2):124-31.

Back to Top